SCHEMBL514322

SCHEMBL514322

CC(=N)C=N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8432459 0.74
SCHEMBL12951671 0.73
SCHEMBL27469501 0.70
SCHEMBL1932218 0.70
SCHEMBL20866681 0.70
SCHEMBL7815907 0.70
SCHEMBL18361475 0.70
SCHEMBL20287542 0.69
SCHEMBL20844097 0.68
SCHEMBL4371206 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6479422-B1 CATALYSTS SELECTED FROM THE GROUP CONSISTING OF DIIMINE NICKEL (II) COMPLEXES AND DIIMINE PALLADIUM (II) COMPLEXES PHILLIPS PETROLEUM COMPANY 2002-11-12 US claimed
CN-116367854-A RNA replicon vaccine against HBV 杨森科学爱尔兰无限公司 2023-06-30 CN disclosed
CN-113574041-A Method for producing bisphenol and method for producing polycarbonate resin 三菱化学株式会社 2021-10-29 CN disclosed
CN-107428709-B Cationic direct dyes 巴斯夫欧洲公司 2021-10-08 CN disclosed
EP-3560983-B1 ETHYLENE VINYL ALCOHOL COPOLYMER PELLETS, RESIN COMPOSITION, AND MULTILAYER STRUCTURE MITSUBISHI CHEM CORP (JP) 2021-04-21 EP disclosed
US-20190054030-A1 METHOD USING ENTERIC-COATED ETIDRONATE FOR TREATING CALCIFICATION, HYPERCALCAEMIA, AND CALCINOSIS OF THE BRAIN AND OTHER ORGANS ZY YTHERAPEUTICS LLC 2019-02-21 US disclosed
CN-107428709-A Cation direct dye 巴斯夫欧洲公司 2017-12-01 CN disclosed
US-9757330-B2 Recipe for in-situ gel, and implant, drug delivery system formed thereby INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-09-12 US disclosed
EP-2890698-B1 DIOXINO- AND OXAZIN-[2,3-D]PYRIMIDINE PI3K INHIBITOR COMPOUNDS AND METHODS OF USE HOFFMANN LA ROCHE (CH) 2017-03-01 EP disclosed
US-9505877-B2 Phenanthro[9,10-B]furan polymers and small molecules for electronic applications BASF SE (DE) 2016-11-29 US disclosed
US-20090264404-A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-10-22 US disclosed
US-20090256468-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-10-15 US disclosed
EP-2096108-A1 Novel organic electroluminescent compounds and organic electroluminscent device using the same Gracel Display Inc. (KR) 2009-09-02 EP disclosed
US-20090186869-A1 Antiviral compounds GILEAD SCIENCES, INC. (US) 2009-07-23 US disclosed
EP-2075309-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-07-01 EP disclosed
EP-1987831-A1 COMPOUNDS EFFECTING GLUCOKINASE AstraZeneca AB (SE) 2008-11-05 EP disclosed
EP-1666465-B1 Composition comprising a tachykinin receptor antagonist and a selective serotonin reuptake inhibitor GLAXO GROUP LTD (GB) 2008-05-07 EP disclosed
EP-1335915-B1 TETRAHYDROBENZAZEPINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS) SMITHKLINE BEECHAM PLC (GB) 2008-01-02 EP disclosed
US-7183276-B2 Azole compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-27 US disclosed
US-4904354-A IMPROVED ADHESION LEARONAL INC. (US) 1990-02-27 US disclosed